| Friedemann Paul | From the Experimental and Clinical Research Center (F.P.), Max Delbrueck Center for Molecular Medicine and Charite Universitaetsmedizin Berlin, INSERM 8 et CNRS UMR5292 Universite Claude Bernard Lyon 1 (R.M.), France John Radcliff Hospital (J.P.) Clinical Neurology Oxford University (J.P.), Centre d'Esclerosi Multiple de Catalunya (Cemcat) Vall d'Hebron Institut de Recerca (G.A.), Vall d'Hebron Hospital Universitari Universitat Autonoma de Barcelona (G.A.), University of Southern Denmark, Slagelse Hospital, University of Colorado Anschutz Medical Campus, UCSF Weill Institute for Neurosciences, University of California San Francisco Department of Neurology (J.D.S.), Hopitaux Universitaires de Strasbourg INSERM U1119 Biopathologie de la Myeline (J.D.S.), Neuroprotection et Strategies Therapeutique Clinical Investigation Center (J.D.S.), Hopitaux Universitaires de Strasbourg, Fukushima Medical University School of Medicine, Southern TOHOKU Research Institute for Neuroscience, Research Institute and Hospital of National Cancer Center, South Korea Oxford PharmaGenesis Ltd (R.H., Walton Centre NHS Foundation Trust, United Kingdom Medical Research Center (N.K.), Marrakesh Medical School, Cadi Ayyad University Neurology Department (N.K.), University Teaching Hospital Mohammed VI, St Josef-Hospital, Ruhr-University Bochum Marianne-Strauss-Klinik (I.K.), Graduate School of Medicine, Chiba University, Japan CIEM MS Research Center (M.L.-P.), Federal University of Minas Gerais, Brazil John Radcliffe Hospital (M.I.L.), University of Oxford, Center for Advanced Neurological Research, Nitte University, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Sydney Medical School, University of Sydney Department of Neurology (S.R.), Concord Hospital, University of Toronto, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), and Universitat de Barcelona, Spain School of Medicine (D.K.S.), Pontifical Catholic University of Rio Grande do Sul, Brazil and Department of Neurology and Laboratory of Neuroimmunology and The Agnes-Ginges Center for Neurogenetics (A.V.-D.), Hadassah-Medical Center, Hebrew University of Jerusalem |
| Bruce A C Cree | From the Experimental and Clinical Research Center (F.P.), Max Delbrueck Center for Molecular Medicine and Charite Universitaetsmedizin Berlin, INSERM 8 et CNRS UMR5292 Universite Claude Bernard Lyon 1 (R.M.), France John Radcliff Hospital (J.P.) Clinical Neurology Oxford University (J.P.), Centre d'Esclerosi Multiple de Catalunya (Cemcat) Vall d'Hebron Institut de Recerca (G.A.), Vall d'Hebron Hospital Universitari Universitat Autonoma de Barcelona (G.A.), University of Southern Denmark, Slagelse Hospital, University of Colorado Anschutz Medical Campus, UCSF Weill Institute for Neurosciences, University of California San Francisco Department of Neurology (J.D.S.), Hopitaux Universitaires de Strasbourg INSERM U1119 Biopathologie de la Myeline (J.D.S.), Neuroprotection et Strategies Therapeutique Clinical Investigation Center (J.D.S.), Hopitaux Universitaires de Strasbourg, Fukushima Medical University School of Medicine, Southern TOHOKU Research Institute for Neuroscience, Research Institute and Hospital of National Cancer Center, South Korea Oxford PharmaGenesis Ltd (R.H., Walton Centre NHS Foundation Trust, United Kingdom Medical Research Center (N.K.), Marrakesh Medical School, Cadi Ayyad University Neurology Department (N.K.), University Teaching Hospital Mohammed VI, St Josef-Hospital, Ruhr-University Bochum Marianne-Strauss-Klinik (I.K.), Graduate School of Medicine, Chiba University, Japan CIEM MS Research Center (M.L.-P.), Federal University of Minas Gerais, Brazil John Radcliffe Hospital (M.I.L.), University of Oxford, Center for Advanced Neurological Research, Nitte University, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Sydney Medical School, University of Sydney Department of Neurology (S.R.), Concord Hospital, University of Toronto, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), and Universitat de Barcelona, Spain School of Medicine (D.K.S.), Pontifical Catholic University of Rio Grande do Sul, Brazil and Department of Neurology and Laboratory of Neuroimmunology and The Agnes-Ginges Center for Neurogenetics (A.V.-D.), Hadassah-Medical Center, Hebrew University of Jerusalem |